Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Kairos Pharma, Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
Kairos Pharma, Ltd. Earnings Date And Information
Kairos Pharma, Ltd. last posted its earnings results on Tuesday, April 15th, 2025. The company reported $-0.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.04 by $0.04. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Kairos Pharma, Ltd. has generated $0 earnings per share over the last year ($-0.23 diluted earnings per share) and currently has a price-to-earnings ratio of -2.7. Kairos Pharma, Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 15th, 2025 based on prior year's report dates.
Kairos Pharma, Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/14/2025 | Q1 2025 | N/A | -$0.08 | N/A | $0 | $0 |
| 04/28/2025 | Q4 2024 | N/A | -$0.08 | N/A | $0 | $0 |
| 11/14/2024 | Q3 2024 | -$0.02 | -$0.10 | -0.08 | $0 | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$0.02 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$0.03 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$0.11 | N/A | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | -$0.03 | N/A | N/A | $0 |
| 06/30/2023 | Q2 2023 | N/A | -$0.02 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$0.01 | N/A | N/A | $0 |
| 12/31/2022 | Q4 2022 | N/A | -$0.02 | N/A | N/A | $0 |
| 09/30/2022 | Q3 2022 | N/A | -$0.02 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$0.04 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.02 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kairos Pharma, Ltd. Earnings: FAQ's
Kairos Pharma, Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 15th, 2025 based offlast year's report dates.
The conference call for Kairos Pharma, Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Kairos Pharma, Ltd.'s latest earnings report can be read online.
Kairos Pharma, Ltd. (:KAPA) has a recorded net income of $-2,603,000.Kairos Pharma, Ltd. has generated $-0.23 earnings per share over the last four quarters.
Kairos Pharma, Ltd. (:KAPA) has a price-to-earnings ratio of -2.7 and price/earnings-to-growth ratio is 0.12.